60 Day FRN

457

Federal Register / Vol. 84, No. 19 / Tuesday, January 29, 2019 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents

Type of respondents

Form name

Hospital CEO/CFO ..........................................

Annual Hospital Interview ..............................

Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–00214 Filed 1–28–19; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–19–1170; Docket No. CDC–2018–
0113]

Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on the data
collection project titled ‘‘Canine
leptospirosis surveillance in Puerto
Rico.’’ This surveillance project aims to
characterize the epidemiology of canine
leptospirosis, assess the applicability of
canine Leptospira vaccines used in
Puerto Rico, and determine potential
rodent, livestock, and wildlife reservoirs
for leptospirosis. Findings from the
study will be used to develop
recommendations for the prevention of
leptospirosis in dogs, focus human
surveillance efforts, and guide further
investigations on leptospirosis in Puerto
Rico.
DATES: CDC must receive written
comments on or before April 1, 2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0113 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
SUMMARY:

VerDate Sep<11>2014

16:14 Jan 28, 2019

Jkt 247001

598

Average
burden
per response
(in hours)
1

2

• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.

3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].

Canine Leptospirosis Surveillance in
Puerto Rico (OMB Control No. 0920–
1170 Exp. Date 03/31/2019)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).

FOR FURTHER INFORMATION CONTACT:

Proposed Data Collection Submitted
for Public Comment and
Recommendations

Number of
responses
per
respondent

Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;

SUPPLEMENTARY INFORMATION:

PO 00000

Frm 00007

Fmt 4703

Sfmt 4703

Proposed Project

Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) Bacterial Special
Pathogens Branch (BSPB) requests for
approval of revisions to existing data
collection tools used in active
surveillance for canine leptospirosis in
Puerto Rico. The methods for data
collection have not changed.
Active surveillance allows for the
collection of prospective data on acute
cases to determine the incidence and
distribution of leptospirosis in dogs,
assess risk factors for infection,
characterize circulating Leptospira
serovars and species, assess
applicability of vaccines currently in
use based on serovar determination, and
assess rodent, livestock, and wildlife
reservoirs of leptospirosis based on
infecting serovars found in dogs.
Findings from this study will aid in the
development of evidence-based,
targeted interventions for the prevention
of canine leptospirosis, be used to focus
human leptospirosis surveillance
efforts, and guide future investigations
on leptospirosis in humans and animals
in Puerto Rico.
The information collection for which
approval sought is in accordance with
BSPB’s mission to prevent illness,
disability, or death caused by bacterial
zoonotic diseases through surveillance,
epidemic investigations, epidemiologic
and laboratory research, training and

E:\FR\FM\29JAN1.SGM

29JAN1

458

Federal Register / Vol. 84, No. 19 / Tuesday, January 29, 2019 / Notices

public education. Authorizing
Legislation comes from Section 301 of
the Public Health Service Act (42 U.S.C.
241). Successful execution of BSPB’s
public health mission requires data
collection activities in collaboration
with the state health department in
Puerto Rico and with local veterinary
clinics and animal shelters participating
in the study.
These activities include collecting
information about dogs that meet the
study case definition for a suspect case
of leptospirosis seen at participating
veterinary clinics and shelters.
Participating veterinarians and their
veterinary staff collect information by
interviewing the dog owner (shelters are
an exception as dog will not have an

history, clinical signs and symptoms,
laboratory results, and clinical outcome.
Approval of this revision ICR will allow
BSPB to continue to collect information
which can help inform animal public
health and will help contribute to a One
Health understanding of leptospirosis in
Puerto Rico.
BSPB estimates involvement of at
least 411 respondents (a minimum 385
from the general public and 26
veterinarians and their veterinary staff)
and estimates a total of 168 hours of
burden for research activities each year.
The collected information will not
impose a cost burden on the
respondents beyond that associated
with their time to provide the required
data.

owner) and reviewing medical and
administrative records, as necessary.
Basic information about the
participating sites will also be collected
for study management and to enhance
data analysis.
Information will be collected using
paper forms and provided in Spanish.
Staff at participating sites find it easier
to complete a paper copy when
abstracting medical record information
and interviewing owners for
information about their dog’s risk
factors and symptoms. Study
coordinators will enter collected data
into an electronic database.
The types of information collected
include information about the dog’s
signalment, location of residence,
environmental risk factors, vaccination

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

Type of respondents

Form name

Veterinarians or veterinary staff ........

26

1

5/60

2

Veterinarians or veterinary staff ........
Veterinarians or veterinary staff ........
Dog owners (general public) .............

Enrollment Questionnaire (Attachment C).
Log Sheet (Attachment D) ...............
Case Questionnaire (Attachment E)
Case Questionnaire (Attachment E)

26
26
624

24
24
1

1/60
10/60
5/60

10
104
52

Total ...........................................

...........................................................

........................

........................

........................

168

Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–00276 Filed 1–28–19; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

VerDate Sep<11>2014

16:14 Jan 28, 2019

Jkt 247001

Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Neurodegeneration Study Section.
Date: January 31–February 1, 2019.
Time: 8:30 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Catamaran Hotel, 3999 Mission
Boulevard, San Diego, CA 92109.
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, [email protected].
This meeting notice is being published less
than 15 days in advance of the meeting due
to the partial Government shutdown of
December 2018.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 18, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–00203 Filed 1–28–19; 8:45 am]
BILLING CODE 4140–01–P

PO 00000

Frm 00008

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer
Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (http://
videocast.nih.gov).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,

E:\FR\FM\29JAN1.SGM

29JAN1